Propanc Biopharma Inc (PPCB)

$2.87 -5.13 (-64.13%)
Market Cap 155,000.00
Revenue (ttm) 0.00
Net Income (ttm) -1.82M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.03
Volume 489,547
Avg Vol 2,732
Day's Range N/A - N/A
Shares Out 19,000.00
Stochastic %K 94%
Beta 2.78
Analysts Strong Buy
Price Target $12.50

Company Profile

Propanc Biopharma, Inc., a development-stage biopharmaceutical healthcare company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia. Its lead product candidate is PRP, an intravenous injection proenzyme treatment designed as a therapeutic option in cancer treatment and prevention which has completed pre-clinical studies. The company has a research and collaboration agreement with the University of Jaén, to undertakes the r...

Industry: Biotechnology
Sector: Healthcare
Phone: 61 3 9882 0780
Fax: 61 3 9882 9969
Address:
302, 6 Butler Street, Camberwell, Australia
Poodoo_90
Poodoo_90 Feb. 3 at 6:41 PM
$PPCB it feels like this is the bottom but absolutely no volume.
0 · Reply
Ataifanboymentalhealthz
Ataifanboymentalhealthz Feb. 3 at 4:28 PM
$PPCB any bottom here?
0 · Reply
Mjv22101
Mjv22101 Feb. 3 at 2:10 AM
$PPCB - Any Thoughts? https://www.stocktitan.net/sec-filings/PPCB/s-1-propanc-biopharma-inc-files-ipo-registration-statement-4745ad52c967.html
1 · Reply
IR_propancbiopharma
IR_propancbiopharma Feb. 2 at 8:04 PM
$PPCB Our accelerating patent activity reinforces Propanc’s leadership in a novel approach focused on preventing cancer recurrence and metastasis. These new filings strengthen protection across formulations, treatment methods, and future indications, while supporting preparations to advance PRP into a Phase 1b first-in-human clinical study. A strong IP foundation is essential to clinical development, partnerships, and long-term value creation.
1 · Reply
Poodoo_90
Poodoo_90 Feb. 2 at 5:53 PM
$PPCB Man this board is quiet. Anyone still here?
2 · Reply
ITMTD
ITMTD Feb. 2 at 3:24 PM
$PPCB Needs some news!
0 · Reply
Poodoo_90
Poodoo_90 Feb. 1 at 10:35 PM
$PPCB Low float biopharma should see a good month!
0 · Reply
Poodoo_90
Poodoo_90 Feb. 1 at 9:49 PM
$PPCB Just need some volume this week!
0 · Reply
Perlaksen
Perlaksen Jan. 31 at 1:45 AM
$TGHL $INEO $PPCB
0 · Reply
Bettertrader1970
Bettertrader1970 Jan. 31 at 12:47 AM
$PPCB if break .20 cents .10 cents coming,then split 1 to 1000 they like that shit ,I am not in just watching 😳
1 · Reply
Latest News on PPCB
Propanc Biopharma Accelerates IP Momentum: Files Fourth Provisional Patent Application in Just Two Months – Strengthening Global Protection for Breakthrough Proenzyme Formulations

Jan 27, 2026, 8:45 AM EST - 7 days ago

Propanc Biopharma Accelerates IP Momentum: Files Fourth Provisional Patent Application in Just Two Months – Strengthening Global Protection for Breakthrough Proenzyme Formulations

Propanc Biopharma Files New Provisional Patent Application for Methods of Producing Trypsinogen & Chymotrypsinogen with IP Australia

Jan 20, 2026, 8:45 AM EST - 14 days ago

Propanc Biopharma Files New Provisional Patent Application for Methods of Producing Trypsinogen & Chymotrypsinogen with IP Australia

Propanc Biopharma Explains How PRP Could Impact Pancreatic Cancer

Jan 15, 2026, 8:45 AM EST - 19 days ago

Propanc Biopharma Explains How PRP Could Impact Pancreatic Cancer

Propanc Biopharma Provides Shareholder Update

Jan 13, 2026, 8:45 AM EST - 21 days ago

Propanc Biopharma Provides Shareholder Update

Propanc Biopharma Publishes Impact of Proenzymes on Pancreatic Ductal Adenocarcinoma Fibroblasts in Peer Reviewed Journal

Dec 22, 2025, 7:00 AM EST - 6 weeks ago

Propanc Biopharma Publishes Impact of Proenzymes on Pancreatic Ductal Adenocarcinoma Fibroblasts in Peer Reviewed Journal

Propanc Biopharma Investigates “Mesenchymal Drift” to Reverse Chronic Diseases Defined by Altos Labs

Dec 4, 2025, 8:45 AM EST - 2 months ago

Propanc Biopharma Investigates “Mesenchymal Drift” to Reverse Chronic Diseases Defined by Altos Labs

Propanc Biopharma Requests Foreign Filing License from Spain for Methods of Treating Resistant Cancer and Fibrosis

Dec 1, 2025, 8:45 AM EST - 2 months ago

Propanc Biopharma Requests Foreign Filing License from Spain for Methods of Treating Resistant Cancer and Fibrosis

Propanc Biopharma Provides Corporate Update and Reports First Quarter 2025/26 Results

Nov 17, 2025, 8:45 AM EST - 2 months ago

Propanc Biopharma Provides Corporate Update and Reports First Quarter 2025/26 Results

Propanc Biopharma, Inc. Secures up to $100 Million Private Placement to Support Digital Asset Acquisition Strategy & Accelerate Company's R&D Pipeline

Nov 10, 2025, 8:45 AM EST - 3 months ago

Propanc Biopharma, Inc. Secures up to $100 Million Private Placement to Support Digital Asset Acquisition Strategy & Accelerate Company's R&D Pipeline

Propanc Biopharma, Inc. Pursues Strategic Acquisition Plan Targeting Digital Asset Treasury (DAT) Companies Trading Below Market Cap to Net Asset Value (MNAV)

Nov 4, 2025, 7:00 AM EST - 3 months ago

Propanc Biopharma, Inc. Pursues Strategic Acquisition Plan Targeting Digital Asset Treasury (DAT) Companies Trading Below Market Cap to Net Asset Value (MNAV)

CORRECTION: Propanc Biopharma Announces Strategic Financing Agreement of up to $100 Million with Hexstone Capital

Oct 15, 2025, 5:45 PM EDT - 3 months ago

CORRECTION: Propanc Biopharma Announces Strategic Financing Agreement of up to $100 Million with Hexstone Capital

Propanc Biopharma Announces Strategic Financing Agreement of up to $100 Million with Hexstone Capital

Oct 15, 2025, 8:45 AM EDT - 3 months ago

Propanc Biopharma Announces Strategic Financing Agreement of up to $100 Million with Hexstone Capital

Propanc Reports End of Fiscal Year Highlights and Outlines Therapeutic Development & $100M+ Digital Asset Treasury Strategy

Oct 7, 2025, 8:45 AM EDT - 4 months ago

Propanc Reports End of Fiscal Year Highlights and Outlines Therapeutic Development & $100M+ Digital Asset Treasury Strategy

Propanc Biopharma Receives Certificate of Grant for “Proenzyme Composition” Patent from US Patent & Trademark Office

Sep 17, 2025, 8:45 AM EDT - 4 months ago

Propanc Biopharma Receives Certificate of Grant for “Proenzyme Composition” Patent from US Patent & Trademark Office

Propanc Biopharma Announces Plan to Acquire $100 Million of Ethereum

Sep 2, 2025, 9:00 AM EDT - 5 months ago

Propanc Biopharma Announces Plan to Acquire $100 Million of Ethereum

Propanc Biopharma Announces Closing of Public Offering and Uplisting to NASDAQ

Aug 19, 2025, 8:30 AM EDT - 6 months ago

Propanc Biopharma Announces Closing of Public Offering and Uplisting to NASDAQ

U.S. IPO Weekly Recap: Bullish And Miami International Complete The Last Major IPOs Of The Summer

Aug 16, 2025, 12:25 AM EDT - 6 months ago

U.S. IPO Weekly Recap: Bullish And Miami International Complete The Last Major IPOs Of The Summer

BLSH BUUU KLAR MAGH MIAX NSRX NUTR

Propanc Biopharma Announces Nasdaq Uplisting and Pricing of $4 Million Public Offering

Aug 14, 2025, 11:00 PM EDT - 6 months ago

Propanc Biopharma Announces Nasdaq Uplisting and Pricing of $4 Million Public Offering

Poodoo_90
Poodoo_90 Feb. 3 at 6:41 PM
$PPCB it feels like this is the bottom but absolutely no volume.
0 · Reply
Ataifanboymentalhealthz
Ataifanboymentalhealthz Feb. 3 at 4:28 PM
$PPCB any bottom here?
0 · Reply
Mjv22101
Mjv22101 Feb. 3 at 2:10 AM
$PPCB - Any Thoughts? https://www.stocktitan.net/sec-filings/PPCB/s-1-propanc-biopharma-inc-files-ipo-registration-statement-4745ad52c967.html
1 · Reply
IR_propancbiopharma
IR_propancbiopharma Feb. 2 at 8:04 PM
$PPCB Our accelerating patent activity reinforces Propanc’s leadership in a novel approach focused on preventing cancer recurrence and metastasis. These new filings strengthen protection across formulations, treatment methods, and future indications, while supporting preparations to advance PRP into a Phase 1b first-in-human clinical study. A strong IP foundation is essential to clinical development, partnerships, and long-term value creation.
1 · Reply
Poodoo_90
Poodoo_90 Feb. 2 at 5:53 PM
$PPCB Man this board is quiet. Anyone still here?
2 · Reply
ITMTD
ITMTD Feb. 2 at 3:24 PM
$PPCB Needs some news!
0 · Reply
Poodoo_90
Poodoo_90 Feb. 1 at 10:35 PM
$PPCB Low float biopharma should see a good month!
0 · Reply
Poodoo_90
Poodoo_90 Feb. 1 at 9:49 PM
$PPCB Just need some volume this week!
0 · Reply
Perlaksen
Perlaksen Jan. 31 at 1:45 AM
$TGHL $INEO $PPCB
0 · Reply
Bettertrader1970
Bettertrader1970 Jan. 31 at 12:47 AM
$PPCB if break .20 cents .10 cents coming,then split 1 to 1000 they like that shit ,I am not in just watching 😳
1 · Reply
aafetygod
aafetygod Jan. 30 at 11:45 PM
$PPCB Conservatively, it looks like it could reach near $2. Maybe it heads back to the 5−6 range?
0 · Reply
aafetygod
aafetygod Jan. 30 at 7:51 PM
$PPCB Why is this (only) 0.2? It wouldn't be strange even if it were 2 dollars...
1 · Reply
REXOM
REXOM Jan. 30 at 7:39 PM
My swings for next week : $TGHL $INEO $PPCB
0 · Reply
Bettertrader1970
Bettertrader1970 Jan. 30 at 7:17 PM
$PPCB I am out completely,move my money to BTC 👈
0 · Reply
IR_propancbiopharma
IR_propancbiopharma Jan. 30 at 6:49 PM
$PPCB Thanks for the questions and for the patient-first perspective. We have been focused on advancing the groundwork for a planned Phase 1b First-In-Human study for PRP. Those steps are part of making the program viable clinically and in the long-term. We promise to share timing or milestones as soon as they are time-stamped through official disclosures, so everyone receives the same information at the same time. We appreciate the engagement and the interest in our science.
1 · Reply
Bettertrader1970
Bettertrader1970 Jan. 30 at 5:19 PM
$PPCB back to green 🔜 💪💰👈
0 · Reply
Poodoo_90
Poodoo_90 Jan. 30 at 5:15 PM
$PPCB
0 · Reply
ITMTD
ITMTD Jan. 30 at 3:49 PM
$PPCB
0 · Reply
ITMTD
ITMTD Jan. 30 at 3:48 PM
$PPCB
0 · Reply
WaveRider666
WaveRider666 Jan. 30 at 3:42 PM
$PPCB - This is what endless, relentless toxic dilution looks like. Yep, that $ figure on the top right side is $100 MILLION.
3 · Reply
Perlaksen
Perlaksen Jan. 30 at 3:41 PM
$PPCB can run fast on low volume
0 · Reply
Bettertrader1970
Bettertrader1970 Jan. 30 at 3:40 PM
$PPCB have big position not selling 💪💰👈
0 · Reply